Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Loek van Alphen

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Human Vaccines|October 27, 2009
Portrait of a leading vaccinologist: dedicated to meningitis and respiratory tract infectionsLoek van Alphen
Methods in Molecular Medicine|October 11, 2002
Diagnosis of infectionAlex van Belkum, Loek van Alphen
Human Vaccines|August 18, 2009
16th International Pathogenic Neisseria Conference: recent progress towards effective meningococcal disease vaccinesAndrew R Gorringe, Loek van Alphen
The New England Journal of Medicine|December 24, 2002
New strains of bacteria and exacerbations of COPDPaul Bresser, Loek van Alphen, René Lutter
Human Vaccines|April 5, 2008
Meningococcal B vaccine development and evaluation of efficacyLoek van Alphen, Germie van den Dobbelsteen
Expert Review of Pharmacoeconomics & Outcomes Research|October 8, 2009
The use of modeling in the economic evaluation of vaccinesJasper M Bos, Loek van Alphen, Maarten J Postma
Microbial Pathogenesis|October 19, 2002
Response regulator important in pathogenesis of Streptococcus suis serotype 2Astrid de Greeff, Herma Buys, Loek van Alphen, et al.
Journal of Clinical Microbiology|August 31, 2002
Distribution of environmentally regulated genes of Streptococcus suis serotype 2 among S. suis serotypes and other organismsAstrid De Greeff, Herma Buys, Robin Verhaar, et al.
Microbiology (Reading, England)|April 1, 1997
Differences in genetic diversity of nonecapsulated Haemophilus influenzae from various diseasesLoek van Alphen, Dominique A Caugant, Birgitta Duim, et al.
Molecular Microbiology|July 19, 2002
Genes of non-typeable Haemophilus influenzae expressed during interaction with human epithelial cell linesPeter van Ulsen, Muriel van Schilfgaarde, Jacob Dankert, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Human Vaccines|October 27, 2009
Portrait of a leading vaccinologist: dedicated to meningitis and respiratory tract infectionsLoek van Alphen
Methods in Molecular Medicine|October 11, 2002
Diagnosis of infectionAlex van Belkum, Loek van Alphen
Human Vaccines|August 18, 2009
16th International Pathogenic Neisseria Conference: recent progress towards effective meningococcal disease vaccinesAndrew R Gorringe, Loek van Alphen
The New England Journal of Medicine|December 24, 2002
New strains of bacteria and exacerbations of COPDPaul Bresser, Loek van Alphen, René Lutter
Human Vaccines|April 5, 2008
Meningococcal B vaccine development and evaluation of efficacyLoek van Alphen, Germie van den Dobbelsteen
Expert Review of Pharmacoeconomics & Outcomes Research|October 8, 2009
The use of modeling in the economic evaluation of vaccinesJasper M Bos, Loek van Alphen, Maarten J Postma
Microbial Pathogenesis|October 19, 2002
Response regulator important in pathogenesis of Streptococcus suis serotype 2Astrid de Greeff, Herma Buys, Loek van Alphen, et al.
Journal of Clinical Microbiology|August 31, 2002
Distribution of environmentally regulated genes of Streptococcus suis serotype 2 among S. suis serotypes and other organismsAstrid De Greeff, Herma Buys, Robin Verhaar, et al.
Microbiology (Reading, England)|April 1, 1997
Differences in genetic diversity of nonecapsulated Haemophilus influenzae from various diseasesLoek van Alphen, Dominique A Caugant, Birgitta Duim, et al.
Molecular Microbiology|July 19, 2002
Genes of non-typeable Haemophilus influenzae expressed during interaction with human epithelial cell linesPeter van Ulsen, Muriel van Schilfgaarde, Jacob Dankert, et al.
Pageof 4